
Articles
-
4 days ago |
optometrytimes.com | Emily Kaiser Maharjan
As of this morning, the Vision Council and Rx have announced a strategic move for the Vision Expo series: Instead of hosting two annual events, Vision Expo East and Vision Expo West, there will be one Vision Expo held in Q1 of each year with the location to rotate around major US cities, starting with Orlando, Florida, in March of 2026. Following the flagship Vision Expo in 2026 in Orlando, the meeting will move to Las Vegas in 2027, New York City in 2028, and an unannounced location for 2029.
-
4 days ago |
optometrytimes.com | Emily Kaiser Maharjan
June 23, 2025By Johnson & Johnson introduces Acuvue Oasys MAX 1-Day multifocal toric lenses, the first and only daily disposable contact lens for astigmatism and presbyopia. Johnson & Johnson unveiled the launch of Acuvue Oasys MAX 1-day multifocal contact lenses for astigmatism, a long-awaited extension of the popular Acuvue Oasys line and the first and only daily disposable contact lens for people with both astigmatism and presbyopia.
-
1 week ago |
optometrytimes.com | Emily Kaiser Maharjan
Following the success of Ray-Ban Meta, EssilorLuxottica and Meta Platforms have joined forces again to launch a new line, Oakley Meta. The Oakley Meta HSTN will be the first to launch in this collection and will be the first ever performance AI glasses, pairing Oakley’s classic sporty design with its PRIZM lenses to give athletes comfortable frames with a technological edge.
-
1 week ago |
optometrytimes.com | Emily Kaiser Maharjan
June 18, 2025By The 128th AOA Congress and 57th AOSA conference will be held in Minneapolis, Minnesota, and will feature a wide variety of symposia, CE, and special events for optometrists, residents, and students.
-
2 weeks ago |
optometrytimes.com | Emily Kaiser Maharjan |Martin Harp
The FDA has approved a new formulation of prednisolone acetate ophthalmic suspension 1% sterile from Amneal Pharmaceuticals. The sterile, topical anti-inflammatory agent is indicated for treating steroid-responsive ocular inflammation and is intended for ophthalmic use only. The suspension references Pred Forte, which is trademarked by Allergan, and AbbVie company. Amneal intends to launch the drop in the third quarter of 2025.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →